HIV Monitoring Quarterly Reports, Second Quarter 2013

* Notice that this is an updated version of a previous report posted on the website. Indicator 8, Figure 8 on page 26 has been updated to correct a technical error. Please discard any previous version and use the updated version instead. This update does not apply to the Northern Health report. If you have any questions please contact Irene Day at iday@cfenet.ubc.ca.

> Back to HIV Monitoring Quarterly Reports

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025